What Is the Correct Pinealon Dosage?
The most commonly reported pinealon dosage in clinical practice is 0.1–0.3 mg per administration, given via subcutaneous injection, typically over a short cycle of 5–10 days repeated periodically. However, there is no FDA-approved dosage and clinical evidence in humans is limited.
Pinealon Dosage Overview
| Parameter | Typical Protocol |
|---|---|
| Dose per injection | 0.1–0.3 mg (100–300 mcg) |
| Route | Subcutaneous injection (most common); intranasal (less common) |
| Frequency | Once daily |
| Cycle length | 5–10 days |
| Cycle frequency | 1–2 times per year (common approach) |
| Storage | Refrigerate after reconstitution; use within 30 days |
Is Pinealon FDA Approved?
No. Pinealon is not FDA approved for any medical indication. It is a peptide bioregulator developed in Russia (originally by the St. Petersburg Institute of Bioregulation and Gerontology) and used clinically in Eastern Europe and Russia, but it has not gone through the US FDA approval process.
In the United States, Pinealon is not commercially available through standard pharmaceutical channels. It may be obtained through:
- Specialty import (legal status is a gray area under FDA enforcement discretion)
- Some international compounding pharmacies
It is not prescribable at licensed US compounding pharmacies because it is not on the FDA's bulk substances list.
Pinealon Administration Methods
Subcutaneous Injection (Most Common)
Pinealon is most commonly reconstituted from lyophilized powder with bacteriostatic water and injected subcutaneously (under the skin), typically in the abdomen or thigh. Use a 27–31 gauge insulin syringe.
Reconstitution: Add 1–2 mL of bacteriostatic water to the lyophilized vial. A 20 mg vial with 2 mL BAC water gives 10 mg/mL concentration.
Intranasal / Sublingual
Some protocols describe intranasal or sublingual administration. These routes have lower bioavailability than injection but are reported by some users as more convenient. Specific dosing adjustments for these routes are not well established.
Pinealon Dosage by Intended Use
Cognitive / Neuroprotective
Most research on Pinealon relates to neuroprotection, with animal studies suggesting benefits for age-related cognitive decline and retinal cell protection. The typical protocol in Eastern European clinical use for cognitive support is:
- 0.1–0.2 mg subcutaneous daily for 5–10 days
- Repeated once or twice annually
Anti-Aging / Longevity
Some providers include Pinealon in broader peptide bioregulator "longevity stacks." In this context it is often combined with Epithalon, Thymogen, or other bioregulators at similar doses.
